Caffeine challenge and breath-holding duration in patients with panic disorder

• Published in: Progress in neuro-psychopharmacology & biological psychiatry Vol. 33; no. 1; pp. 41 - 44
• Main Authors: Masdrakis, Vasilios G., Markianos, Manolis, Vaidakis, Nikolaos, Papakostas, Yiannis G., Oulis, Panagiotis
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier Inc 01-02-2009; Elsevier
• Subjects: Adult; Adult and adolescent clinical studies; Anxiety disorders. Neuroses; Asphyxia - metabolism; Biological and medical sciences; Breath-holding duration; Caffeine - adverse effects; Caffeine challenge test; Carbon Dioxide - metabolism; Female; Humans; Male; Medical sciences; Neuropharmacology; Panic disorder; Panic Disorder - chemically induced; Panic Disorder - etiology; Panic Disorder - physiopathology; Pharmacology. Drug treatments; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Respiration; CO 2; DSM-IV; Caffeine challenge test; PD; Breath-holding duration; BH; Panic disorder; Human; Panic; CNS stimulant; Psychotropic; Anxiety disorder; Xanthine derivatives; Duration; Caffeine
• ISSN: 0278-5846; 1878-4216
• DOI: 10.1016/j.pnpbp.2008.10.002

Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO
2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake.
BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test.
Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers.
Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO
2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO
2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.